DNM1L and cardiomyopathy: In this study, we proposed the hypothesis that NEU1 was a mediator of DOX-induced cardiomyopathy and NEU1 inhibitor could improve DOX-induced cardiac dysfunction through modulating Drp1-dependent mitochondrial fission and mitophagy.